GIPPONI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 957
EU - Europa 256
AS - Asia 114
SA - Sud America 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.333
Nazione #
US - Stati Uniti d'America 954
CN - Cina 73
IT - Italia 56
UA - Ucraina 48
DE - Germania 35
FI - Finlandia 34
HK - Hong Kong 29
IE - Irlanda 26
GB - Regno Unito 21
PL - Polonia 14
FR - Francia 12
IN - India 5
BR - Brasile 3
CA - Canada 3
TR - Turchia 3
AT - Austria 2
CZ - Repubblica Ceca 2
SE - Svezia 2
VN - Vietnam 2
AU - Australia 1
BE - Belgio 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
IR - Iran 1
MA - Marocco 1
PH - Filippine 1
RU - Federazione Russa 1
Totale 1.333
Città #
Ashburn 135
Fairfield 133
Woodbridge 84
Seattle 65
Chandler 64
Houston 60
Cambridge 54
New York 51
Ann Arbor 42
Wilmington 34
Jacksonville 32
Princeton 32
Dearborn 29
Hong Kong 28
Helsinki 25
Dublin 20
Warsaw 14
Washington 11
Shanghai 10
Brescia 8
Nanchang 8
Nanjing 8
San Diego 8
Beijing 6
Changsha 6
Lancaster 6
Milan 6
Des Moines 5
Kunming 5
London 5
Cascina 4
Cologno Monzese 4
Jiaxing 4
Lappeenranta 4
Taizhou 4
Verona 4
Boardman 3
Jinan 3
Los Angeles 3
Ningbo 3
Rio De Janeiro 3
San Francisco 3
Toronto 3
Deiva Marina 2
Dong Ket 2
Guangzhou 2
Haikou 2
Kocaeli 2
Olomouc 2
Orange 2
Palermo 2
Pavia 2
Rho 2
Shenyang 2
Tianjin 2
Zhengzhou 2
Augusta 1
Brussels 1
Castiglione delle Stiviere 1
Changchun 1
Chicago 1
Chongqing 1
Cremona 1
Falkenstein 1
Hangzhou 1
Hebei 1
Hounslow 1
Kilburn 1
Leawood 1
Manila 1
Marsciano 1
Melbourne 1
New Bedfont 1
New Delhi 1
Norwalk 1
Pesaro 1
Pian di Scò 1
Piraeus 1
Presezzo 1
Redwood City 1
Rovato 1
Sabz 1
San Cesareo 1
San Mateo 1
Scafati 1
Siena 1
Suri 1
Taiyuan 1
Tallinn 1
Tavagnacco 1
Vienna 1
Totale 1.100
Nome #
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 140
COVID-19 impact on consecutive neurological patients admitted to the emergency department 138
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 135
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 132
Where SUNCT Contacts TN: A Case Report 125
Potentially Serious Drug-Drug Interactions in Older Patients Hospitalized for Acute Ischemic and Hemorrhagic Stroke 113
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 109
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 105
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 75
Plasma Cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease 37
Long-term neurological manifestations of COVID-19: prevalence and predictive factors 36
Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection 33
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease 33
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 31
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 30
Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with lewy bodies 28
Neurological and Mental Health Symptoms Associated with Post-COVID-19 Disability in a Sample of Patients Discharged from a COVID-19 Ward: A Secondary Analysis 18
Predictors of “brain fog” 1 year after COVID-19 disease 18
Neurological involvement associated with COVID-19 disease: a study on psychosocial factors 17
Premorbid vulnerability and disease severity impact on Long-COVID cognitive impairment 12
Increased risk of functional neurological disorders following SARS‐CoV‐2 vaccination 9
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection 5
Totale 1.379
Categoria #
all - tutte 7.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.722


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201953 0 0 0 0 0 0 0 0 0 0 26 27
2019/2020239 27 7 8 26 15 35 39 27 15 24 6 10
2020/2021347 7 53 31 18 59 52 7 21 17 28 15 39
2021/2022156 6 27 3 4 12 7 6 14 12 12 18 35
2022/2023178 18 5 2 4 33 36 2 28 31 1 8 10
2023/2024263 20 4 40 14 17 97 5 14 32 4 16 0
Totale 1.379